| ECAL Cements Market-Leading Position with Acquisition of Rokt Calendar |
Globe Newswire |
06/04 |
13:00 |
| Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting |
Globe Newswire |
06/03 |
11:00 |
| Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting |
Globe Newswire |
06/02 |
23:00 |
| Jet.AI to Present at the Maxim Group Virtual TMT Conference on Tuesday, June 4, 2024 |
Globe Newswire |
05/31 |
12:30 |
| Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO |
Globe Newswire |
05/31 |
12:00 |
| Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress |
Globe Newswire |
05/31 |
11:30 |
| Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences |
Globe Newswire |
05/30 |
20:01 |
| Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides |
Globe Newswire |
05/29 |
10:40 |
| Cellectis Reports Financial Results for First Quarter 2024 |
Globe Newswire |
05/28 |
20:30 |
| Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024 |
Globe Newswire |
05/24 |
10:00 |
| DraftKings Completes Acquisition of Jackpocket |
Globe Newswire |
05/23 |
11:00 |
| Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates |
Globe Newswire |
05/17 |
11:00 |
| Correction Notice of First Quarter 2024 Financial Results Press Release |
Globe Newswire |
05/16 |
17:29 |
| Seattle Kraken Bring on WatchGuard’s Unified Security Platform® |
Globe Newswire |
05/16 |
04:01 |
| Jet.AI Reports First Quarter 2024 Financial Results |
Globe Newswire |
05/15 |
21:29 |
| Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates |
Globe Newswire |
05/15 |
20:15 |
| Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results |
Globe Newswire |
05/15 |
20:05 |
| Gildan Activewear Board of Directors Issues Letter to Shareholders |
Globe Newswire |
05/15 |
11:30 |
| Sportradar Reports First Quarter 2024 Financial and Operating Results |
Globe Newswire |
05/15 |
11:00 |
| Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress |
Globe Newswire |
05/14 |
14:00 |
| Indy 500 Coverage Returns to TuneIn on May 14 |
Globe Newswire |
05/14 |
12:00 |
| Sportradar’s Alpha Odds Increased Profits By 15% for Operators Across UEFA Euro 2024 Qualifying Matches |
Globe Newswire |
05/13 |
07:16 |
| New to The Street Airs Corporate Interviews, Televised Episodes 573 and 574 as Sponsored Programming on Bloomberg TV and The FOX Business Network |
Globe Newswire |
05/10 |
14:16 |
| Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights |
Globe Newswire |
05/09 |
20:01 |
| ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
05/09 |
20:00 |
